A 76-year-old woman with heart failure with reduced ejection fraction (LVEF 30%) is stable in clinic. She is currently on Ramipril 10 mg once daily an...

Question

A 76-year-old woman with heart failure with reduced ejection fraction (LVEF 30%) is stable in clinic. She is currently on Ramipril 10 mg once daily and Bisoprolol 5 mg once daily. Her eGFR is 55 mL/min/1.73 m² and potassium 4.6 mmol/L. She is NYHA class II. According to current guidance, which additional drug class should be added to improve prognosis?

Accepted Answer

A mineralocorticoid receptor antagonist such as Spironolactone.

Answer

A thiazide diuretic such as Bendroflumethiazide.

Answer

A rate-limiting calcium-channel blocker such as Verapamil.

Answer

An alpha-blocker such as Doxazosin.

Answer

A short-acting nitrate such as Glyceryl trinitrate spray.

uk-plab-1 MCQ (SBA): Chronic heart failure with reduced ejection fraction